News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges Caitlin E. Cox November 21, 2025
News Conference News TCT 2025 Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE Caitlin E. Cox October 28, 2025
News Daily News Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis Todd Neale August 13, 2025
News Daily News Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes Michael O'Riordan June 20, 2025
News Daily News Pressure-Based Physiological Testing Results Diverge Between LAD, LCx Caitlin E. Cox May 29, 2025
News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Daily News Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA Michael O'Riordan February 24, 2025
News Conference News TCT 2024 In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI Yael L. Maxwell October 29, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Conference News ESC 2024 ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions Michael O'Riordan September 17, 2024
News Daily News With ANOCA, Better to Test Coronary Function in Multiple Vessels Caitlin E. Cox May 29, 2024
News Conference News EuroPCR 2024 FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI Caitlin E. Cox May 20, 2024
News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Daily News INOCA May Be at the Root of Angina for Many Long-COVID Patients Caitlin E. Cox April 17, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024